List of articles with "Psoriasis"

First IL-23p19 Antibody

First IL-23p19 Antibody

China Suzhou Psoriasis Innovent PECONDLE
Healthy Skin Month

Healthy Skin Month

United States New York Psoriasis American Skin Association Vitiligo
Psoriasis Treatment Preferences

Psoriasis Treatment Preferences

USA Johnson & Johnson Spring House Psoriasis Oral Treatments
Icotrokinra Promises Relief

Icotrokinra Promises Relief

USA Johnson & Johnson Spring House Psoriasis Icotrokinra
World Psoriasis Day 2025

World Psoriasis Day 2025

USA mental health Stockholm Psoriasis IFPA
Psoriasis Awareness 2025

Psoriasis Awareness 2025

None Psoriasis IFPA World Psoriasis Day
Stop the Domino Effect

Stop the Domino Effect

None Psoriasis IFPA World Psoriasis Day
Psoriasis Awareness 2025

Psoriasis Awareness 2025

Sweden mental health Stockholm Psoriasis IFPA
GLP-1RAs and Psoriasis

GLP-1RAs and Psoriasis

None Psoriasis Heart Health GLP-1RA
GLP-1RAs and Psoriasis

GLP-1RAs and Psoriasis

None Paris Psoriasis EADV Congress GLP-1RAs
GLP-1RAs and Psoriasis

GLP-1RAs and Psoriasis

USA Paris Cardiovascular Psoriasis GLP-1RA
GLP-1RA and Psoriasis

GLP-1RA and Psoriasis

Paris France Psoriasis Health GLP-1RA
Icotrokinra vs Deucravacitinib

Icotrokinra vs Deucravacitinib

USA Spring House Psoriasis Icotrokinra Deucravacitinib
BIMZELX® Efficacy

BIMZELX® Efficacy

USA Atlanta UCB Psoriasis BIMZELX
Psoriasis at UN Assembly

Psoriasis at UN Assembly

USA New York Psoriasis IFPA UN Assembly
Psoriasis at UNGA

Psoriasis at UNGA

None New York Psoriasis IFPA UNGA
Psoriasis Focus at UNGA

Psoriasis Focus at UNGA

None New York Psoriasis NCDs IFPA
IFPA at UNGA: Psoriatic Awareness

IFPA at UNGA: Psoriatic Awareness

USA New York Psoriasis NCDs IFPA
ICOTROKINRA Moves Forward

ICOTROKINRA Moves Forward

USA Johnson & Johnson Spring House Psoriasis Icotrokinra
Doctor-Patient Gap

Doctor-Patient Gap

Japan Tokyo Psoriasis Communication Medilead
FDA Approves ASC50

FDA Approves ASC50

USA Hong Kong Psoriasis Ascletis ASC50
Icotrokinra's Promising Efficacy

Icotrokinra's Promising Efficacy

USA Johnson & Johnson Spring House Psoriasis Icotrokinra
Ebdarokimab Approved

Ebdarokimab Approved

China Hong Kong Akeso Psoriasis Ebdarokimab
Garfunkel on Psoriasis

Garfunkel on Psoriasis

Psoriasis ILUMYA Art Garfunkel
Positive Results for SFA-002

Positive Results for SFA-002

United States Psoriasis SFA Therapeutics SFA-002 Jenkintown
ILUMYA® Nail Psoriasis Study

ILUMYA® Nail Psoriasis Study

USA Princeton Psoriasis ILUMYA Sun Pharma
New Psoriasis Drug Highlights

New Psoriasis Drug Highlights

United States Orlando Psoriasis AAD 2025 SFA Therapeutics
BIMZELX® Efficacy Results

BIMZELX® Efficacy Results

USA Orlando UCB Psoriasis BIMZELX
Positive Phase 3 Results for Yesintek

Positive Phase 3 Results for Yesintek

India Bengaluru Biocon YESINTEK Psoriasis
Gumokimab for Psoriasis

Gumokimab for Psoriasis

China Hong Kong Akeso Psoriasis Gumokimab
InventisBio D-2570 Study

InventisBio D-2570 Study

China Shanghai D-2570 InventisBio Psoriasis

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.